Skip to content

A clinical trial to study the effects of two different doses of injection hyperbaric ropivacaine in spinal anaesthesia for lower abdominal and leg surgeries.

Comparison of two different doses of hyperbaric ropivacaine in spinal anaesthesia for infraumbilical surgeries- a randomized controlled trial. - ROSA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046357
Enrollment
120
Registered
2022-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Injection 0.75% hyperbaric ropivacaine.: Dose- 2cc. Route of administration- Intrathecal for spinal anaesthesia.Frequency of administration- Single shot. Duration of monitoring-For six

Sponsors

Dr Prashant Atmaram Lomate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.ASA grade I or grade II patients 2.Either sex 3.Age- 18 to 60 years 4.Scheduled for elective infraumbilical surgeries under spinal anaesthesia.

Exclusion criteria

Exclusion criteria: 1.Patient refusal to participate in the study. 2.Known hypersensitivity to local anaesthetics 3.Bleeding disorders 4.Anatomic abnormality of spine 5.Severe systemic diseases 6.Pregnant patients

Design outcomes

Primary

MeasureTime frame
duration of analgesia after 2cc and 2.4cc volumes of 0.75% hyperbaric ropivacaine when given for spinal anaesthesia during infraumbilical surgeries.Timepoint: duration of analgesia- assesses for 24 hours.

Secondary

MeasureTime frame
1.onset times of sensory and motor block. 2.duration of sensory and motor block 3.haemodynamic parameters [HR, SBP,DBP, MAP] 4. adverse effects of study drugs and incidence of discontinuation of therapy due to side effects. Timepoint: 1. Sensory block duration- for 6 hours. 2.motor block -for 6 hours. 3.VAS scores-for 6 hours. 4. HR, SBP,DBP,MAP, SPO2- for 6 hours.;1.onset times of sensory and motor block. 2.duration of sensory and motor block 3.haemodynamic parameters [HR, SBP,DBP, MAP] 4. adverse effects of study drugs and incidence of discontinuation of therapy due to side effects. Timepoint: 1. Sensory block duration- for 6 hours. 2.motor block -for 6 hours. 3.VAS scores-for 6 hours. 4. HR, SBP,DBP,MAP, SPO2- for 6 hours.

Countries

India

Contacts

Public ContactDr Prashant Atmaram Lomate

medical college

drprashantlomate@gmail.com02332212780

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026